Pulmonary Sarcoidosis Investigational Medication

Trial Objective

Pulmonary Sarcoidosis Investigational MedicationThis research study evaluates an investigational medication called Acthar® Gel (Acthar) as a potential treatment of pulmonary sarcoidosis.


This trial is active and currently recruiting.

Who Can Participate

People with biopsy-confirmed sarcoidosis for more than a year.

Age: 18-90    Gender: Any Gender

Estimated Time Commitment

Participants in the study inject the medication twice a week at home and have appointments every 4 weeks.

Study participants will need to fast prior to their visits. Visit lengths will vary.



Trial Contact

For more information, contact:

Carmen Egidio

Carmen Egidio

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Mallinckrodt Pharmaceuticals

Principal Investigators

Request More Information